Chemical Structure : VT103
CAS No.: 2290608-13-6
Catalog No.: PC-72506Not For Human Use, Lab Use Only.
VT103 (VT-103) is a specific small molecule inhibitor of YAP/TAZ-TEAD-dependent transcription with IC50 of 1.2 nM in YAP reporter assay, selectively blocks TEAD1 auto-palmitoylation.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $188 | In stock | |
10 mg | $298 | In stock | |
25 mg | $488 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
VT103 (VT-103) is a specific small molecule inhibitor of YAP/TAZ-TEAD-dependent transcription with IC50 of 1.2 nM in YAP reporter assay, selectively blocks TEAD1 auto-palmitoylation.
VT103 appears to be TEAD1-selective, as it does not block palmitoylation of TEAD2, TEAD3, or TEAD4 in HEK293T cells transfected with plasmid expressing MYC-tagged full-length TEAD1, TEAD2, TEAD3, or TEAD4 protein, with no effect on RAS palmitoylation.
VT103 selectively binds directly to TEAD1 in the central lipid pocket, reduces YAP interaction with TEAD1 but not TEAD4 in NF2-mutant NCI-H2373 cells.
VT103 blocked the proliferation of NF2-deficient or NF2-mutated mesothelioma cell lines, 100- to 1,000-fold less activity in NF2 wild-type mesothelioma cells.
VT103 (3 mg/kg once daily, oral) block growth of NF2-deficient mesothelioma xenografts, exhibited strong antitumor efficacy, leading to tumor regression, even at 1 and 0.3 mg/kg once daily.
M.Wt | 410.415 | |
Formula | C18H17F3N4O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-methyl-3-(1-methyl-1H-imidazol-4-yl)-4-((4-(trifluoromethyl)phenyl)amino)benzenesulfonamide |
1. Tracy T Tang, et al. Mol Cancer Ther. 2021 Jun;20(6):986-998.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright